PMC:7402624 / 29105-29336 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T249","span":{"begin":9,"end":13},"obj":"Body_part"},{"id":"T250","span":{"begin":141,"end":146},"obj":"Body_part"},{"id":"T252","span":{"begin":225,"end":229},"obj":"Body_part"}],"attributes":[{"id":"A249","pred":"fma_id","subj":"T249","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A250","pred":"fma_id","subj":"T250","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A252","pred":"fma_id","subj":"T252","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"se for B cell populations for all subjects; row-scaled z-score. (L) Percentage of cohort in each EMD group. (M) Global viSNE projection of B cells for all subjects pooled, with EMD groups 1-3 concatenated and overlaid. (N) B cell c"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T500","span":{"begin":7,"end":13},"obj":"http://purl.obolibrary.org/obo/CL_0000236"},{"id":"T501","span":{"begin":139,"end":146},"obj":"http://purl.obolibrary.org/obo/CL_0000236"},{"id":"T502","span":{"begin":223,"end":229},"obj":"http://purl.obolibrary.org/obo/CL_0000236"}],"text":"se for B cell populations for all subjects; row-scaled z-score. (L) Percentage of cohort in each EMD group. (M) Global viSNE projection of B cells for all subjects pooled, with EMD groups 1-3 concatenated and overlaid. (N) B cell c"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T197","span":{"begin":101,"end":106},"obj":"Chemical"}],"attributes":[{"id":"A197","pred":"chebi_id","subj":"T197","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"se for B cell populations for all subjects; row-scaled z-score. (L) Percentage of cohort in each EMD group. (M) Global viSNE projection of B cells for all subjects pooled, with EMD groups 1-3 concatenated and overlaid. (N) B cell c"}